1

Associations of TMEM88 methylation and expression with patient clinical and pathological features

CharacteristicsGroupMethylationExpression
n Low n (%) High n (%) χ2P n Low n (%) High n (%) χ2P
Age (years)≤ 6021356 (54)47 (46)1.3640.24320150 (51)48 (49)0.0460.831
> 6051 (46)59 (54)51 (50)52 (50)
StageI-II20874 (53)65 (47)0.8680.35119758 (48)64 (52)0.9430.331
III-IV32 (46)37 (54)41 (55)34 (45)
BMI≤ 2421259 (52)55 (48)0.1620.68719948 (49)51 (51)0.1260.723
> 2448 (49)50 (51)51 (51)49 (49)
GenderMale21358 (47)66 (53)1.4220.23320165 (52)61 (48)0.2420.623
Female49 (55)40 (45)36 (48)39 (52)
History of lung diseasesNo21397 (50)98 (50)0.2230.63720194 (51)91 (49)0.2940.588
Yes10 (56)8 (44)7 (44)9 (56)
Family historyNo21290 (51)88 (49)0.0040.95220081 (50)81 (50)0.0850.770
Yes17 (50)17 (50)20 (53)18 (47)
Smoking statusNo21343 (57)33 (43)1.9020.16820125 (42)34 (58)2.0720.150
Yes64 (47)73 (53)76 (54)66 (46)
HistologyLUSC18540 (42)55 (58)6.6830.01016752 (53)47 (47)0.7760.378
LUAD55 (61)35 (39)31 (46)37 (54)
Tumor size (cm)< 321246 (66)24 (34)9.7130.00220030 (52)28 (48)0.0970.755
≥ 361 (43)81 (57)70 (49)72 (51)